This review systematically elucidates the pivotal role of CXCL13 in obesity-related metabolic inflammation, providing a theoretical foundation for the development of precision intervention strategies tailored to disease subtypes, stages, and specific organ targeting. This evidence concerns the gene CXCL13 and obesity due to melanocortin 4 receptor deficiency.